- Home
- LPSN vs APLT Comparison
LPSN vs APLT Comparison
Compare LPSN & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- APLT
- Stock Information
- Founded
- LPSN 1995
- APLT 2016
- Country
- LPSN United States
- APLT United States
- Employees
- LPSN N/A
- APLT N/A
- Industry
- LPSN EDP Services
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- LPSN Technology
- APLT Health Care
- Exchange
- LPSN Nasdaq
- APLT Nasdaq
- Market Cap
- LPSN 81.6M
- APLT 80.3M
- IPO Year
- LPSN 2000
- APLT 2019
- Fundamental
- Price
- LPSN $0.95
- APLT $0.54
- Analyst Decision
- LPSN Hold
- APLT Buy
- Analyst Count
- LPSN 5
- APLT 7
- Target Price
- LPSN $0.98
- APLT $6.10
- AVG Volume (30 Days)
- LPSN 1.3M
- APLT 1.9M
- Earning Date
- LPSN 03-05-2025
- APLT 05-08-2025
- Dividend Yield
- LPSN N/A
- APLT N/A
- EPS Growth
- LPSN N/A
- APLT N/A
- EPS
- LPSN N/A
- APLT N/A
- Revenue
- LPSN $312,474,000.00
- APLT N/A
- Revenue This Year
- LPSN N/A
- APLT N/A
- Revenue Next Year
- LPSN $1.72
- APLT $2,426.33
- P/E Ratio
- LPSN N/A
- APLT N/A
- Revenue Growth
- LPSN N/A
- APLT N/A
- 52 Week Low
- LPSN $0.45
- APLT $0.43
- 52 Week High
- LPSN $2.08
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- LPSN 41.60
- APLT 45.98
- Support Level
- LPSN $0.84
- APLT $0.49
- Resistance Level
- LPSN $1.09
- APLT $0.62
- Average True Range (ATR)
- LPSN 0.07
- APLT 0.06
- MACD
- LPSN 0.01
- APLT 0.02
- Stochastic Oscillator
- LPSN 36.52
- APLT 48.89
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation.. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.